Stephanie Price
Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".
Stephanie Price · page 63
- Medical
Cannabis company receives approval for COVID-19 dose finding study
MGC Pharma has received approval for a dose finding study for its proprietary treatment for the effects of COVID-19.
- CBD Market
UK Advertising Standards Agency upholds CBD advert complaint
The ASA has ruled that the advert breached the UK Code of Broadcast Advertising rules 13.6 and 13.6.2.
- Cultivation
Dry flower export pathway opens up for Flora Growth
Flora Growth has received its GACP Certification to international GMP active pharmaceutical ingredient producers.
- Cultivation
GMP certification allows Linneo Health to continue cannabis research
Linneo Health has had its GMP certification renewed for its quality control laboratory and its post-harvest facility.
- CBD Market
A 200-year old Welsh recipe utlitising CBD to create a unique product
Mon Naturals working on a Class 1 Medical Device made of hemp polymer to create a plant-based wound dressing.
- Uncategorized
Powered by British Cannabis
British Cannabis™ has been busier than ever in 2021, building plans for future growth. The cornerstone of this endeavour will be the Winter 2021 relaunch of its flagship pharmacy CBD brand – Canabidol™.
- Pharmaceutical
Oxford Cannabinoid Technologies expects to list on OCT QB in November
Harbour Access has been appointed as North American investor relations advisor to provide support for the listing.
- Companies
Life sciences company to expand into medical cannabis market
Broughton will be focusing on accelerating products to market within strategic markets including the cannabinoids industry.
- Medical
European Medicines Agency gives cannabinoid medicine positive opinion
Tetra Bio-Pharma’s has received a positive opinion from the EMA’s Committee for Orphan Medicinal Products on its application for Orphan Drug Designation for QIXLEEF.
- Cultivation
Cannabis regulation changes across Switzerland and Luxembourg
It is hoped that the changes will move consumers away from the black market.
- CBD Market
Cannabis investment company to see UK and Europe growth
US cannabis investment company Thought Leaders has acquired UK CBD brand mellow.
- CBD Market
How COVID has and will continue to change the cannabis market
Canxchange looks at how COVID-19 has impacted the cannabis market.
